Literature DB >> 18180058

Assessment of IVC filter efficacy in prevention of pulmonary thrombo-embolism by 99mTc-MAA lung perfusion scintigraphy--a case series and review of literature.

Rajesh Vijayvergiya, Bhagwant Rai Mittal, Anil Grover, Vuppaladadhiam Hariram, Anish Bhattacharya, Baljinder Singh.   

Abstract

INTRODUCTION: Anticoagulant therapy is the standard treatment of venous thrombo-embolism (VTE). Permanent inferior vena cava (IVC) filter is an important adjunctive therapy in these patients to prevent the complications like potentially fatal pulmonary embolism and chronic thrombo-embolic pulmonary hypertension. We studied patients with proximal deep vein thrombosis (DVT) of lower limbs and recurrent pulmonary thrombo-embolism (PTE), who were put on permanent IVC filters for the prevention of further episodes of PTE. The efficacy of filters in prevention of PTE was assessed by clinical history and was supported by follow-up (99m)Tc-MAA lung perfusion scintigraphy. METHODS AND
RESULTS: We prospectively enrolled 7 patients of PTE, who were put on IVC filter from July 2002-April 2005. All patients had (99m)Tc-MAA lung perfusion scan before filter implantation. Percutaneous IVC filter placement in infra-renal position was done. All patients were put on adequate oral anticoagulant treatment with target INR of 2.0-3.0. At follow-up two patients died - one died of intractable right heart failure at 6 months and other died of carcinoma colon metastasis after 16 months. The mean follow-up of rest of five patients was 3.5 years (range 20-54 months), and none of them had clinically evident further episode of DVT or PTE. Their repeat lung perfusion scan at 1 year of follow-up showed marked improvement in perfusion with no evidence of additional fresh/new defects.
CONCLUSION: Follow-up (99m)Tc-MAA lung perfusion scan in PTE patients, who are on IVC filter, can demonstrate the significant improvement in lung perfusion secondary to prevention of further pulmonary embolism episodes and resolution of pulmonary thrombus by continued anticoagulant therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18180058     DOI: 10.1016/j.ijcard.2007.08.120

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  99mTc-zolmitriptan: radiolabeling, molecular modeling, biodistribution and gamma scintigraphy as a hopeful radiopharmaceutical for lung nuclear imaging.

Authors:  H M Rashed; F A Marzook; H Farag
Journal:  Radiol Med       Date:  2016-09-01       Impact factor: 3.469

2.  The perioperative use of oral anticoagulants during surgical procedures for carpal tunnel syndrome. A preliminary study.

Authors:  R D S Nandoe Tewarie; R H M A Bartels
Journal:  Acta Neurochir (Wien)       Date:  2010-02-07       Impact factor: 2.216

3.  Retrievable Inferior Vena Cava Filter and Catheter Directed Thrombolysis (CDT) for Treating a 19-year-old Man with Acute Myeloid Leukemia Complicated by Deep Vein Thrombosis (DVT): A Case Report.

Authors:  Hiromi Muranishi; Ryosuke Zushi; Hiroki Nagata; Koji Hasegawa; Atsushi Nakagawa; Hidefumi Hamada
Journal:  Ann Vasc Dis       Date:  2011-04-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.